Status:
COMPLETED
T-Cell Project: Epidemiologic Component
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Peripheral T-Cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
Background: * The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical...
Detailed Description
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation with different morphological pat...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age greater than or equal to 18 years
- Histologically confirmed Periperal T-cell lymphoma on or after September 1, 2006
- EXCLUSION CRITERIA:
- Age less than 18 years
- Cases without histological confirmation
- Cases diagnosed prior to September 1, 2006
Exclusion
Key Trial Info
Start Date :
June 18 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2011
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00705809
Start Date
June 18 2008
End Date
July 20 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892